Serafini Randal A, Frere Justin J, Giosan Ilinca M, Nwaneshiudu Chinwe A
Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, USA.
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.
Brain Behav Immun Health. 2025 Mar 24;45:100983. doi: 10.1016/j.bbih.2025.100983. eCollection 2025 May.
The acute and post-acute sequelae of SARS-CoV-2 infection have been of great clinical interest since the inception of the COVID-19 pandemic. Despite a high prevalence of individuals with persistent symptoms, a wholistic view of the effects of SARS-CoV-2 on special sensory systems is lacking. Considering the significant impact of normal sensory function on quality of life, the goal of this review is to highlight unresolved issues related to SARS-CoV-2-associated insults to the sensory nervous system.
In this narrative review, we discuss the epidemiology of SARS-CoV-2-induced sensory perturbations, underlying pathological mechanisms, and possible therapeutic strategies across the olfactory, gustatory, somatosensory, visual, and auditory systems. Examined literature included studies with human biospecimens, human-derived cell lines, and naturally susceptible animal models, which highlighted evidence of persistent functional disruption in all sensory systems. SARS-CoV-2 infection was associated with persistent inflammation in the olfactory epithelium/bulb, somatosensory ganglia, and gustatory systems, long-term transcriptional perturbations in the sensory central nervous system and peripheral nervous system, and detectable degeneration/apoptosis in the gustatory and visual systems. Few studies have proposed evidence-based therapeutic strategies for attenuating specific sensory abnormalities after SARS-CoV-2 infection.
While the olfactory system, and to some extent the visual and somatosensory systems, have been more thoroughly investigated from symptomatology, behavioral and molecular perspectives, there is still an unmet need for the development of therapeutics to treat COVID-induced impairment of these systems. Further, additional attention must be placed on COVID-associated impairment of the gustatory, visual, and auditory systems, which lack detailed mechanistic investigations into their pathogenesis.
自新冠疫情爆发以来,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的急性和急性后后遗症一直是临床关注的重点。尽管有持续症状的个体患病率很高,但目前仍缺乏对SARS-CoV-2对特殊感觉系统影响的全面认识。鉴于正常感觉功能对生活质量有重大影响,本综述的目的是强调与SARS-CoV-2相关的感觉神经系统损伤有关的未解决问题。
在本叙述性综述中,我们讨论了SARS-CoV-2引起的感觉障碍的流行病学、潜在病理机制以及嗅觉、味觉、躯体感觉、视觉和听觉系统的可能治疗策略。所审查的文献包括对人类生物标本、人类来源细胞系和天然易感动物模型的研究,这些研究突出了所有感觉系统中持续功能破坏的证据。SARS-CoV-2感染与嗅觉上皮/嗅球、躯体感觉神经节和味觉系统的持续炎症、感觉中枢神经系统和外周神经系统的长期转录扰动以及味觉和视觉系统中可检测到的变性/凋亡有关。很少有研究提出基于证据的治疗策略来减轻SARS-CoV-2感染后的特定感觉异常。
虽然从症状学、行为学和分子学角度对嗅觉系统以及在一定程度上对视觉和躯体感觉系统进行了更深入的研究,但仍需要开发治疗方法来治疗新冠病毒引起的这些系统损伤。此外,必须更加关注新冠病毒对味觉、视觉和听觉系统的损害,目前对这些系统发病机制缺乏详细的机制研究。